This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Lorna G. MacDougall, MB, ChB, DCH

JAMA. 1982;247(1):53-54.

Abstract
Pure red cell aplasia developed in a 9-year-old girl receiving sodium valproate therapy. Infection with measles and chickenpox had occurred two months previously. Regeneration of bone marrow erythroid precursors was demonstrated one month after drug withdrawal. Readministration of sodium valproate resulted in a second episode of red cell aplasia that again resolved promptly after drug withdrawal. The respective roles of infection and drugs in the etiology of red cell aplasia are discussed.

(JAMA 1982;247:53-54)

Author Affiliations
From the Department of Paediatrics, Metabolic and Nutrition Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Footnotes
Reprint requests to the Metabolic and Nutrition Research Unit, Baragwanath Hospital, PO Bertsham 2013, South Africa (Dr MacDougall).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Temporary Pure Red-Cell Aplasia During Valproate Monotherapy: Clinical Observations and Spectral Electroencephalographic Aspects
Farkas et al.
J Child Neurol 2000;15:485-487.
ABSTRACT  

Transient Myeloid Dysplasia Due to Valproic Acid
Hongeng et al.
CLIN PEDIATR 1997;36:361-364.